首页 | 本学科首页   官方微博 | 高级检索  
     

卡维地洛治疗慢性充血性心力衰竭疗效观察
引用本文:陈锐亮. 卡维地洛治疗慢性充血性心力衰竭疗效观察[J]. 医学理论与实践, 2009, 22(7): 749-750
作者姓名:陈锐亮
作者单位:广东省深圳市龙岗区葵涌人民医院,518119
摘    要:目的:探讨卡维地洛对慢性充血性心力衰竭(Chronic Congestive Heart Failure,CHF)的疗效和安全性。方法:将71例慢性充血性心力衰竭患者随机分为卡维地洛组(治疗组)和常规治疗组(对照组),对比两组治疗前、6个月后左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)、左室射血分数(LVEF)、心率、血压和心功能变化情况,观察卡维地洛的疗效和安全性。结果:卡维地洛组左室舒张末期内径、左室收缩末期内径、血压降低、心率减慢、左室射血分数、心功能分级明显提高,与对照组比较差异有显著性(P<0.05)。结论:卡维地洛治疗慢性充血性心力衰竭能改善心功能,改善左室重塑,使用安全,疗效显著。

关 键 词:卡维地洛  充血性心力衰竭  治疗结果

The Clinical Observation of Curative Effect of Carvedilol for Chronic Congestive Heart Failure
CHEN Ruiliang. The Clinical Observation of Curative Effect of Carvedilol for Chronic Congestive Heart Failure[J]. The Journal of Medical Theory and Practice, 2009, 22(7): 749-750
Authors:CHEN Ruiliang
Affiliation:CHEN Ruiliang.( Kui yong People' s Hospital, Longgang District, Shenzhen City, Guangdong Province 518119)
Abstract:Objective:To investigate the curative effect and safety of carvedilol treatment on chronic congestive heart failure (CHF).Methods:71 cases with CHF were randomly divided into two groups:the carvedilol treatment group (treated group) and the conventional treatment group (control group), comparing changes of the left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter (LVESD),left ventricular ejection fraction (LVEF),heart rate, blood pressure, cardiac function in two groups between before and after six-months' treatment, in order to observe the curative effect and safety of carvedilol.Results:The LVEDD,LVESD,blood pressure and heart rate reduces,and LVEF,cardiac function classification raised significantly.And the difference compared to control group had significance(P<0.05).Conclusion:The carvedilol improve the cardiac function, enhance the remodeling of left ventricular,and it is safe and effective.
Keywords:Carvedilol  Congestive heart failure  Therapeutic result
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号